The market for organ preservation solutions is driven by rising transplant surgeries due to chronic illnesses and aging ...
Bridge to Life has received FDA De Novo clearance for its VitaSmart hypothermic oxygenated perfusion (HOPE) system for liver ...
LOS ANGELES, Oct. 20, 2023 (GLOBE NEWSWIRE) -- The Global Perfusion Systems Market Size accounted for USD 1.3 Billion in 2022 and is projected to achieve a market size of USD 1.9 Billion by 2032 ...
The FDA clearance enables the commercial use of VitaSmart (TM) for hypothermic oxygenated perfusion of donor livers following static cold storage and prior to transplantation, providing a clear, ...
Therapeutic hypothermia of donors didn't preserve kidney function as well as machine perfusion of the organ during cold storage, a randomized trial found. Compared with kidneys pumped with a ...
Innovations in bioprocessing have led to rapid advancements in biological therapies, positively impacting the lives of millions. One less-recent innovation, which has seen a refreshed surge in ...
Potential for improved product quality and cost/time savings is reviving interest in perfusion technology. Tuomas Kujansuu/E+/Getty Images Perfusion technology was first introduced in the late 1980s ...
Melanoma incidence in the United States has increased during recent decades to an estimated number of 76,100 new cases in 2014, 1 comprising 4.6% of all new cancer cases. In approximately 5% to 8% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results